Domenico Accili, M.D., da230@columbia.edu
Insulin resistance in diabetes: Genetics, molecular biology and animal models.
Qais Al-Awqati, M.B., Ch.B., qa1@columbia.edui
Developmental biology of the kidney biogenesis of epithelial polarity; chloride channels and
cystic fibrosis.
Gerald Appel, M.D., gba2@columbia.edu
Treatment of glomerulonephritis and the nephrotic syndrome; lipids and renal disease.
Selim Arcasoy, M.D., F.C.C.P., F.A.C.P., sa2059@columbia.edu
Lung transplantation and rejection; lung reduction surgery for emphysema; idiopathic pulmonary fibrosis and pulmonary alveolar proteinosis; pulmonary embolism and thrombolytic therapy.
Deborah Davis Ascheim, M.D., dda18@columbia.edu
Pharmacologic therapies for heart failure; investigational surgical techniques and mechanical assist devices for patients with end-stage congestive heart failure; altered thyroid hormone metabolism in patients with congestive heart failure.
Arthur Bank, M.D., bank@cancercenter.columbia.edu
Gene transfer and expression in bone marrow cells; regulation of human hemoglobin gene expression; molecular biologic analysis of regulation of human globin biosynthesis.
Jonathan Barasch, M.D., Ph.D., jmb4@columbia.edu
The ureteric bud secretes proteins that induce nearby mesenchyme to convert to epithelia and form nephrons. The aim of my work is to identify these factors and to determine how they change cell fate in the embryonic kidney.
R. Graham Barr, M.D., Dr.P.H., rgb9@columbia.edu
Novel risk factors for asthma and chronic obstructive pulmonary disease (COPD).
Randolph C. Barrows, Jr., M.D., barrows@flux.cpmc.columbia.edu
Computerized patient records; information systems in ambulatory care; clinical data warehouses; automated decision support; controlled medical vocabularies; health data modeling; smoking cessation pharmacotherapies and techniques.
Robert C. Basner, M.D., rcb42@columbia.edu
Cardiopulmonary regulation during sleep; autonomic and vascular correlates of sleep-disordered breathing.
Steven R. Bergmann, M.D., Ph.D., srb40@columbia.edu
Paul D. Berk, M.D., pb2158@columbia.edu
The disposition of long chain free fatty acids (FFA); lipid metabolism, transport physiology, obesity, diabetes, and fatty liver, and who is interested in cellular physiology, transport kinetics, cell and molecular biology and translational research methods.
Rachel Bijou, M.D., rb540@columbia.edu
Clinical research in congestive heart failure.
J. Thomas Bigger, M.D., jtb2@columbia.edu
Studies in the prediction and prevention of sudden cardiac death. Studies of the role of the autonomic nervous system in the genesis of malignant ventricular arrhythmias.
John P. Bilezikian, M.D., jpb2@columbia.edu
Regulation of signal transduction pathways by parathyroid hormone and parathyroid hormone-related protein. Clinical and basic features of metabolic bone diseases such as primary hyperparathyroidism; osteoporosis in women and men.
William Blaner, Ph.D., wsb2@columbia.edu
Regulation of vitamin A and retinoic acid metabolism.
David Brenner, M.D., dab2106@columbia.edu
Intracellular signaling in the liver under normal and pathophysiological states; using animal models of human diseases including transgenic mice combined with cultures of primary and immortalized cells to study in particular the role of NFkB and JNK.
Anne Marie Brilliantes, M.D., ab647@columbia.edu
Genetic basis of Type 1 and Type 2 diabetes mellitus with specific emphasis on the cellular and molecular biology of the pancreatic beta cell.
Robert S. Brown, Jr., M.D., M.P.H., rb464@columbia.edu
Determinants of the cost of orthotopic liver transplantation and the impact of organ allocation strategies on cost and outcome; outcomes including quality of life in chronic liver disease; clinical trials in liver disease and transplantation.
Karen Brudney, M.D., Harkness 6, kfb2@columbia.edu
Clincal research on HIV and tuberculosis in Washington Heights and in the Dominican Republic.
Matthew Burg, Ph. D., mb2358@columbia.edu
The role of stress and emotion in CHD related prognosis, and the mechanisms underlying this role.
Daniel Burkhoff, M.D., Ph.D., db59@columbia.edu
Mechanics of the failing heart; experimental models of heart failure; angiogenesis.
Vincent P. Butler, Jr., M.D., vpb2@columbia.edu
Studies of the effects of digitalis and related compounds on nerve conduction in demyelinating disease both in humans (multiple sclerosis) and in mice (experimental allergic encephalomyelitis).
Stephen M. Canfield, M.D., Ph.D., smc12@columbia.edu
T lymphocyte migration; T cell interaction with the extracellular matrix, specifically laminin; molecular structure/function analysis of the 67kD non-integrin laminin binding protein on activated T cells.
Olveen Carrasquillo, M.D., M.P.H., oc6@columbia.edu
Health service/health policy research; access to care/racial and ethnic disparities; the uninsured; minority/Latino health; managed care; Medicare/Medicaid.
Rita Charon, M.D., Ph.D., rac5@columbia.edu
Studies in literature and medicine; imagination as a clinical instrument; patient-doctor discourse; narrative writing in medicine.
Leonard Chess, M.D., lc19@columbia.edu
Functional and molecular biological studies of cell surface molecules involved in T cell function. Basic and clinical studies of T cell subsets important in the immunopathogenesis of autoimmune, infectious and neoplastic diseases.
James Cimino, M.D., jjc7@columbia.edu
Studies in medical informatics, computerized medical knowledge bases and medical decision-making.
Raphael Clynes, M.D., Ph.D., rc645@columbia.edu
Our laboratory studies the role of Fc receptors in autoimmunity and tumor immunity.
David Cobrinik, M.D., Ph.D.,
Function and regulation of retinoblastoma (Rb) family proteins in cell cycle control, development, and oncogenesis; cellular senescence and differentiation.
David J. Cohen, M.D., djc5@columbia.edu
New immunosuppressive therapies in renal transplantaion; renal disease in recipients of heart, liver and lung transplants.
Paolo Colombo, M.D., pcc2001@columbia.edu
We conduct translational (clinical/basic) studies to determine the expression of pro-inflammatory genes in the vascular endothelium of patients with diabetes and of patients with heart failure. Using a novel approach, endothelial cells are biopsied from peripheral vessels of patients, and then characterized by real time PCR, flow cytometry and immunofluorescent analysis.
James Coromilas, M.D., jc47@columbia.edu
Studies on the mechanisms of ventricular tachycardia. Studies of the effects of antiarrhythmic drugs on re-entrant circuits. Studies on ablation of ventricular tachycardia.
Katherine D. Crew, M.D., M.S., kd59@columbia.edu
Breast cancer prevention and control.
Hayes Dansky, M.D., hmd2101@columbia.edu
Identifying cellular and molecular mechanisms by which diabetes and obesity accelerate atherosclerosis and the response to arterial injury.
Jeanine D’Armiento, M.D., Ph.D., jmd12@columbia.edu
Studies on the role of matrix metalloproteinases in disease by the use of transgenic mouse models.
Jonathan David, M.D., FACP, FACG, jd165@columbia.edu
Colon cancer screening; cost issues in healthcare, using endoscopy as a model.
Karina W. Davidson, Ph.D., kd2124@columbia.edu
Behavioral Medicine randomized controlled trials with cardiology patients.
Mario Deng, M.D., md785@columbia.edu
Outcomes evaluation of medical and surgical therapies in advanced heart failure and the underlying molecular and cellular pathophysiology, with specific emphasis on the interleuken-6 cytokine system.
Betty Diamond, M.D., bd2137@columbia.edu
B cell repertoire selection, immune-mediated neuropsychiatric syndromes, induction and pathogenicity of anti-DNA antibodies.
Emily DiMango, M.D., ead3@columbia.edu
Clinical research includes treatment and management of patients with chronic obstructive airway disease (COPD and asthma); member of the National Emphysema Treatment Trial (NETT); caring for patients with pulmonary complications related to cancer and its treatment.
Marco R. DiTullio, M.D., md42@columbia.edu
Echocardiographic assessment of cardiac embolic sources for ischemic stroke, especially aortic plaques. Applications of echocardiography to epidemiologic studies on cardioembolic stroke.
Jay F. Dobkin, M.D., jfd2@columbia.edu
Pathogenesis of pneumococcal infection in AIDS; epidemiology of tuberculosis associated with AIDS.
Phillip Factor, D.O., phf2103@columbia.edu
Mechanisms of pulmonary edema clearance, role and regulation of lung ?ü2-adrenergic receptors, treatment of acute lung injury, gene therapies for acute and acquired diseases.
Anthony Ferrante Jr., M.D., Ph.D., awf7@columbia.edu
Large increases in fat mass lead to obesity and adversely alter blood pressure, insulin sensitivity, serum lipid profiles and cardiac function. Research focuses on identifying cellular and molecular mechanisms by which changes in fat mass alter medically important traits, including insulin sensitivity and cardiac mass.
Robert L. Fine, M.D., rlf20@columbia.edu
Translational cancer research into the mechanisms of cancer drug resistance in the lab to the clinical implementation of novel therapeutic trials to improve outcome based on lab research.
Michael J. Flamm, M.D., Ph.D., mjf3@columbia.edu
Retroviral gene transfer in the treatment of paroxysmal noctural hemoglobinuria.
Robert Foronjy, M.D., rff5@columbia.edu
Emphysema.
Pamela Freda, M.D., puf1@columbia.edu
Clinical studies of pituitary tumors. Adrenal function in HIV infection.
Harold Frucht, M.D., hf2011@columbia.edu
Gastrointestinal malignancies and pre-malignant conditions, specifically hereditary syndromes and cancer genetics; acid hypersecretory states and GI hormone excess syndromes. Translational research in gastrointestinal cancer biology.
Paul Gaglio, M.D., pg2011@columbia.edu
Treatment of viral Hepatitis pre and post liver transplantation, liver regeneration, living donor liver transplantation, fatty liver disease.
Ali Ghavari, M.D., ag2239@columbia.edu
Molecular genetics of renal diseases, in particular glomerular disorders in humans and rodent models.
Elsa-Grace V. Giardina, M.D., evg1@columbia.edu
Heart disease in women; mechanism of action of estrogen and other drugs to reduce cardiac risk in women.
Victor Grann, M.D., M.P.H., vrg2@columbia.edu
Health outcomes, cost-effectiveness and decision analysis, quality of life, and disparities of cancer care and prevention.
William A. Gray, M.D., wg2131@columbia.edu
Peripheral vascular intervention, percutaneous valve therapy, non-surgical modalities for stroke prevention (carotid stenting and patent foramen ovale (PFO) closure), and research into preventing the reoccurrence of disease following successful angioplasty or stenting.
Henry N. Ginsberg, M.D., hmg1@columbia.edu
Assembly and secretion of lipoproteins from cultured liver cells. Studies of insulin resistance and dyslipidemia in transgenic mouse models. Regulation of lipid and lipoprotein metabolism in humans.
Robin S. Goland, M.D., rsg2@columbia.edu
Clinical diabetes studies.
Ira J. Goldberg, M.D., ijg3@columbia.edu
Regulation of human lipoprotein lipase, transport from fat cells to endothelial cells.
Rochelle Goldsmith, Ph.D., rlg11@columbia.edu
Exercise physiology; mechanisms of exercise limitation in heart failure; exercise training and left ventricular remodeling.
Peter H.R. Green, M.D., pg11@columbia.edu
Celiac disease: clinical presentation, manifestations and complications; genetic analysis, immunologic mechanisms and pathogenesis.
Steven Greenberg, M.D., smg8@columbia.edu
Molecular studies of macrophage cytoskeleton. Signal transduction of Fc receptors. Molecular biology of phagocytosis.
Scott Hammer, M.D., smh48@columbia.edu
Antiretroviral therapy; HIV drug resistance; pathogenesis of HIV infection.
Dawn Hershman, M.D., M.S., dlh23@columbia.edu
Clinical trials in breast and gynecologic malignancies, supportive care and cancer survivorship.
Charles Hesdorffer, M.D., hesdorffer@cancenter.columbia.edu
Marrow and stem cell transplant program and the cellular immunotherapy program of Columbia University.
Kevan Herold, M.D., kh318@columbia.edu
Mechanisms of autoimmune diabetes; new approaches to treatment and induction of tolerance to the autoimmune response.
Shunichi Homma, M.D., sh23@columbia.edu
Cardiac hemodynamics studied with transesophageal echocardiography. Stress echocardiography. Relationship of intracardiac shunts to the occurrence of cerebral ischemic events. Intravascular ultrasound. Cost effectiveness of echocardiograph for different disease processes.
Evelyn M. Horn, M.D., emh3@columbia.edu
Neurohormonal mechanisms of adrenergic dysfunction in congestive heart failure; clinical studies in heart failure. Clinical research in primary pulmonary hypertension.
George Hripcsak, M.D., gh13@columbia.edu
Medical informatics: Medical knowledge-based systems; sharing electronic knowledge across institutions; electronic medical record.
Li-Shin Huang, Ph.D., lh99@columbia.edu
Molecular genetics of lipoproteins. Molecular and cellular mechanisms of apo B expression, including transgenic and knockout mouse models for lipid transport and male infertility.
Hong Jiang, M.D., Ph.D., hj4@columbia.edu
Cellular and molecular mechanisms of immunoregulation by the CD8+ T cells in peripheral tolerance; molecular biologic analysis of interaction between CD8+ and CD4+ T cells; CD8+ T cell mediated control of autoimmunity.
Andrew Joe, M.D., akj3@columbia.edu
Evaluating cancer prevention agents and identifying surrogate tumor markers for use in targeted clinical chemoprevention; ongoing translational, patient-oriented projects, in which I am investigating Barrett’s Esophagus and African-American Breast Cancer.
Ulrich P. Jorde, M.D., upj1@columbia.edu
Renin-angiotensin system in congestive heart failure.
Steven Kawut, M.D. , sk2097@columbia.edu
Determinants and prediction of outcome for patients with pulmonaryarterial hypertension and for patients who are undergoing lung transplantation.
Judith Korner, M.D., Ph.D., jk181@columbia.edu
Clinical studies and basic research in the pathogenesis and treatment of obesity and insulin resistance.
Etah Kurland, M.D., esk11@columbia.edu
New therapeutic approaches to the treatment of osteoporosis in men; family studies/genetic studies of osteoporosis.
Donald Landry, M.D., Ph.D., dwl1@columbia.edu
Artificial enzymes directed against cocaine, nerve gas, and other targets; vasopressin deficiency and hypersensitivity in shock.
Rafael Lantigua, M.D., ral4@columbia.edu
Mentoring minority investigators in aging research; genetics of Alzheimer’s Disease.
Seth Lederman, M.D., Ph.D, sl11@columbia.edu
Studies of molecules involved in the interaction of T cells with B cells important in antibody formation. Molecular investigations of cell surface molecules and lymphokines important in immunodeficiency states and autoimmune diseases.
Marianne Legato, M.D., mjl2@columbia.edu
Delineating the differences in men and women’s normal physiology and in their experience of the same diseases.
Rudolph L. Leibel, M.D., rl232@columbia.edu
Molecular genetics and energetics of obesity and Type 2 diabetes in rodents and humans.
Barron H. Lerner, M.D., bhl5@columbia.edu
Medical ethics and the history of medicine, especially regarding breast cancer and informed consent.
Charles J. Lightdale, M.D., cjl18@columbia.edu
Diagnosis and treatment of Barrett’s esophagus and early esophageal cancer; studies in magnification endoscopy, endoscopic ultrasonography and photodynamic therapy.
Franklin Lowy, M.D., fl189@columbia.edu
Research involves the pathogenesis and transmission of Staphylococcus aureus.
Jeremy Luban, M.D., jl45@columbia.edu
Molecular biology of HIV-1 replication and pathogenesis; regulation of T cell cytokine
production.
Jose Luchsinger, M.D., jal94@columbia.edu
Relationship between cardiovascular risk factors and cognition. Relationship between diet and cognition.
Meggan Mackay, M.D., M.S., mcm2123@columbia.edu
Clinical research in autoimmune disease focussing on Systemic Lupus Erythematosus.
Arthur Magun, M.D., amm3@columbia.edu
Clinical trials in the treatment of chronic hepatitis.
Donna Mancini, M.D., dmm31@columbia.edu
Cardiac transplantation; immunosuppressive surveillance and therapy. Mechanisms of exercise intolerance in heart failure.
Andrew R. Marks, M.D., arm42@columbia.edu
Molecular cardiology; structure and function of calcium channels and their regulation in the pathogenesis of heart failure and cardiac arrhythmias.
Steven Marx, M.D., sm460@columbia.edu
Ion channels in the heart and their regulation by kinases and phosphatases through the formation of macromolecular complexes.
Mathew Maurer, M.D., msm10@columbia.edu
Syncope; isolated systolic hypertension; diastolic heart failure.
Roger A. Maxfield, M.D., ram7@columbia.edu
Multicenter clinical trials of bronchoscopic lung volume reduction.
Rachel Miller, M.D., rlm14@columbia.edu
Clinical and basic science research in asthma and allergies, including IL-4 signaling, development of in- utero sensitization to indoor allergens, evaluation of polymorphisms in IL-4Ra.
Jane H. Morse, M.D., jhm4@columbia.edu
Genetics of pulmonary arterial hypertension; pathophysiological role of mutations of BMPR2 and other members of the TGF-B superfamily.
Lori Mosca, M.D., M.P.H., Ph.D., ljm10@columbia.edu
Clinical trials and outcomes research in cardiovascular disease prevention and women’s health; novel technologies to screen for heart disease; effect of preventive therapies on endothelial function.
Alan J. Moskowitz, M.D., ajm4@columbia.edu
Clinical evaluative research of new interventions for cardiovascular disease, (e.g., mechanical ventricular assist devices and endovascular repair of aortic aneurysms). Particular interest in measuring survival, quality of life, and economic impact.
Issam Moussa, M.D., im2132@columbia.edu
Study of cerebral hemodynamics in patients with carotid occlusive disease before undergoing coronary bypass surgery and before and after carotid artery stenting; study of the relationship between peripheral arterial disease and depression; study of outcome of patients undergoing drug-eluting stent implantation in complex coronary anatomy.
Jean Mulder, M.D., jm669@columbia.edu
Clinical investigation of osteoporosis, particularly in young women with premature ovarian failure and in survivors of childhood cancer.
Alfred I. Neugut, M.D., Ph.D., ain1@columbia.edu
Studies in cancer epidemiology and cancer screening.
Gbenga Ogedegbe, M.D., M.P.H., M.S., goo1@columbia.edu
Minority Health Research. Improving medication adherence in hypertensive African-Americans.
Juan Oliver, M.D., jao7@columbia.edu
Angiogenesis during kidney development; ATP-sensitive K+ channels and regulation of vascular tone.
Ariel Pablos-Mendez, M.D., M.P.H., ap39@columbia.edu
Epidemiology of tuberculosis. Epidemiology of cardiovascular disease (elderly and minorities). Clinical preventive services.
Walter Palmas-Molinger, M.D., wp56@columbia.edu
Telemedicine. Prevention of cardiovascular diseases. Effects of nutritional supplementation on chronic, low level serum inflammation. Identification and causes of subclinical atherosclerosis.
Kyriakos Papadopoulos, M.D., kdp29@columbia.edu
Clinical studies of peptide and cell-based immunotherapy for cancer.
Ramon E. Parsons, M.D., Ph.D., rep15@columbia.edu
Genetic and biochemical analysis of breast cancer.
Alessandra Pernis, M.D., abp1@columbia.edu
Molecular mechanisms of B cell development and function.
Daniel P. Petrylak, M.D., dpp5@columbia.edu
Clinical and laboratory research in the mechanism of hormonal and chemotherapeutic resistance in prostate and bladder cancer.
Thomas Pickering, M.D., D.Phil. tp2114@columbia.edu
Behavioral aspects of hypertension and heart disease.
Geoffrey S. Pitt, M.D., Ph.D., gp2004@columbia.edu
Ion channels in the heart and brain; structural and biophysical properties of voltage-gated calcium channels; calcium-regulated gene expression in the heart and brain.
Charles Powell, M.D., cap6@columbia.edu
Lung cancer: CT screening, biomarker development and validation for early diagnosis, molecular epidemiology, gene expression profiles and preoperative risk assessment.
Leroy E. Rabbani, M.D., ler8@columbia.edu
Regulation of vascular smooth muscle cell fibrinolysis and migration; role of thrombosis in atherosclerosis and angioplasty restenosis.
Jai Radhakrishnan, M.D., M.R.C.P., jr55@columbia.edu
Glomerular disease; outcomes research in dialysis and transplantation.
Harry Raftopoulos, M.D., hr43@columbia.edu
Clinical and translational research in the treatment of lung cancer.
Ravi Ramasamy, Ph.D., rr260@columbia.edu
Metabolic basis of ischemic injury and heart failure; molecular and cellular impact of polyol pathway.
James A. Reiffel, M.D., jar2@columbia.edu
Diagnosis and treatment of cardiac rhythm disorders (arrhythmias).
Carlos Jose Rodriguez, M.D., MPH, FACC, cjr10@columbia.edu
Echocardiography and cardiovascular disease epidemiology; particularly hypertensive heart disease among underrepresented minorities.
Michael Rosenbaum, M.D., mr475@columbia.edu
Regulation of body weight and the pathogenesis of type 2 diabetes in adults and children.
David J. Rothman, Ph.D., djr5@columbia.edu
The ethics of human experimentation, in the U.S. and developing countries; the social implications of genetic enhancement technologies; the social and ethical issues in organ donation and transplantation.
Paul Rothman, M.D., pbr3@columbia.edu
Regulation of signaling pathways in normal and malignant lymphocytes. Molecular studies of the immunopathogenesis of allergic disorders.
Moshe Rubin, M.D., mr43@columbia.edu
Wireless Capsule Endoscopy of the small intestine.
Chris Schindler, M.D., Ph.D., cw54@columbia.edu
Cytokine signal transduction and the role it plays in immunity, atherosclerosis and asthma.
Neil Schluger, M.D., ns311@columbia.edu
Our laboratory studies aspects of the human host immune response against tuberculosis.
Larry Schulman, M.D., lls2@columbia.edu
Lung transplantation; clinical studies in immune suppression and lung injury.
Allan Schwartz, M.D., as20@columbia.edu
Hemodynamics of lateral ventricular mechanical devices.
Neil Shachter, M.D., nss5@columbia.edu
Mouse models of triglyceride metabolism.
Elizabeth Shane, M.D., es54@columbia.edu
Metabolic bone disease associated with cardiac, lung, renal, liver and bone marrow transplantation. Pathophysiology and clinical studies of osteoporosis, primary hyperparathyroidism and other metabolic bone diseases.
Steven Shea, M.D., ss35@columbia.edu
Studies in cardiovascular epidemiology and cardiovascular disease prevention.
Shonni J. Silverberg, M.D., sjs5@columbia.edu
Pathophysiology and clinical studies of osteoporosis, primary hyperparathyroidism and other metabolic bone diseases.
Ethel S. Siris, M.D., es27@columbia.edu
Paget’s disease of bone, osteoporosis and metabolic bone diseases.
Robert J. Sommer, M.D., rs2463@columbia.edu
Interventional Catheterization for Adult Congenital Heart Disease; Patent Foramen Ovale: Stroke/Migraine.
Susan F. Steinberg, M.D., sfs1@columbia.edu
Cardiomyocyte beta-adrenergic receptors; basic cellular mechanisms and novel strategies to treat heart failure; protease-activated receptor signal transduction in cardiomyocytes, a link between inflammation and cardiomyopathy.
Leonard Stern, M.D., ls38@columbia.edu
Long-term survival in peritoneal dialysis: contributing factors such as hematocrit; cardiovascular disease prevention in hemodialysis patients using lipid-lowering therapy.
Peter D. Stevens, M.D., pds5@columbia.edu
New technique and outcomes research in pancreaticobiliary diseases and GI bleeding.
Milan N. Stojanovic, Ph.D., mns18@columbia.edu
Oligonucleotide-based fluorescent probes for small molecules and proteins; directed movement of catalytic nanoassemblies; recognition-triggered drug delivery systems; decision-making molecular networks.
Ira Tabas, M.D., Ph.D., iat1@columbia.edu
Mechanisms and consequences of atherosclerotic foam cell formation.
Alan Tall, M.D., art1@columbia.edu
Plasma lipoproteins; cell and molecular biology of atherosclerosis.
Robert N. Taub, M.D., Ph.D., rnt1@columbia.edu
Drug discovery; molecular biology of mesothelioma and sarcoma; clinical trials in sarcoma, mesothelioma and melanoma.
Jie Wang, M.D., Ph.D., jw147@columbia.edu
Experimental models of heart failure; role of coronary circulation in disease regression.
Sharon Wardlaw, M.D., sw22@columbia.edu
Neuroendocrine control of pituitary function; hypothalamic neuropeptides and regulation of energy homeostasis.
Michelle Warren, M.D., mpw1@columbia.edu
Effects of exercise and weight loss on the hypothalamic-pituitarygonadal axis and the metabolic signals to the GnRH pulse generator, and on the development of osteopenia in women. Treatment of the menopausal woman. Effects of puberty on behavior.
Hal Wasserman, M.D., hsw1@columbia.edu
Adjunctive treatments for myocardial infarction; reperfusion therapy; transplant-related coronary artery disease.
I. Bernard Weinstein, M.D., ibw1@columbia.edu
Molecular mechanisms of carcinogenesis, utilizing cell culture systems and molecular genetics; growth factors and signal transduction.
Carrie Welch, Ph.D., cbw13@columbia.edu
Using a mouse genetics approach to identify new genes underlying susceptibility to atherosclerosis and thrombosis.
Robert Winchester, M.D., rjw8@columbia.edu
How HLA genes act as antigen-presenting structures and selectors of the T-cell repertoire to determine susceptibility to auto-immune diseases and influence the outcome of infections such as HIV.
Howard Worman, M.D., hjw14@columbia.edu
Molecular cell biology of the nuclear envelope, its biogenesis, dynamics in cell division and pathobiology in cancer. Cell biology of hepatitis C virus infection.
Yi-Hao Yu, M.D., Ph.D., yy102@columbia.edu
Lipid and energy metabolism, insulin resistance, and diabetes.